Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niko Pasanen

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
BJU International|May 10, 2024
Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate CancerNiko Pasanen, Kirsi Talala, Sebastiaan Remmers, et al.
BJU International|July 4, 2026
Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC)Niko Pasanen, Kirsi Talala, Sebastiaan Remmers, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
BJU International|May 10, 2024
Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate CancerNiko Pasanen, Kirsi Talala, Sebastiaan Remmers, et al.
BJU International|July 4, 2026
Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC)Niko Pasanen, Kirsi Talala, Sebastiaan Remmers, et al.
Pageof 1